Sigma receptors as potential therapeutic targets for neuroprotection

European Journal of Pharmacology

Volumn 743, Issue , 2014, Pages 42-47

  Nguyen, Linda ^a   Kaushal, Nidhi ^a,b   Robson, Matthew J ^a,c   Matsumoto, Rae R ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b TAKEDA PHARMACEUTICALS   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

Glia; Neurodegeneration; Neurotoxicity; Sigma receptors

Indexed keywords

METHAMPHETAMINE; SIGMA OPIATE RECEPTOR; SIGMA RECEPTOR LIGAND; LIGAND; NEUROPROTECTIVE AGENT;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ASTROCYTE; BRAIN MITOCHONDRION; CEREBROVASCULAR ACCIDENT; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG TARGETING; ENDOPLASMIC RETICULUM STRESS; EXCITOTOXICITY; HUMAN; HUNTINGTON CHOREA; MICROGLIA; NERVE CELL LESION; NERVE DEGENERATION; NEUROMODULATION; NEUROPROTECTION; NEUROTOXICITY; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETINA DEGENERATION; ANIMAL; METABOLISM; NEURODEGENERATIVE DISEASES;

ANIMALS; HUMANS; LIGANDS; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; RECEPTORS, SIGMA;

EID: 84915752573     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.09.022     Document Type: Article

References (50)

1. C.T. Ajmo Jr., D.O. Vernon, L. Collier, K.R. Pennypacker, and J. Cuevas Sigma receptor activation reduces infarct size at 24 h after permanent middle cerebral artery occlusion in rats Curr. Neurovasc. Res. 3 2006 89 98
2. D. Balasuriya, A.P. Stewart, and J.M. Edwardson The sigma-1 receptor interacts directly with GluN1 but not GluN2A in the GluN1/GluN2A NMDA receptor J. Neurosci.:Off. J. Soc. Neurosci. 33 2013 18219 18224
3. A.A. Behensky, I.E. Yasny, A.M. Shuster, S.B. Seredenin, A.V. Petrov, and J. Cuevas Afobazole activation of sigma-1 receptors modulates neuronal responses to amyloid-beta25-35 J. Pharmacol. Exp. Ther. 347 2013 468 477
4. A.A. Behensky, I.E. Yasny, A.M. Shuster, S.B. Seredenin, A.V. Petrov, and J. Cuevas Stimulation of sigma receptors with afobazole blocks activation of microglia and reduces toxicity caused by amyloid-beta25-35 J. Pharmacol. Exp. Ther. 347 2013 458 467
5. K.W. Crawford, and W.D. Bowen Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines Cancer Res. 62 2002 313 322
6. M. Czeh, P. Gressens, and A.M. Kaindl The yin and yang of microglia Dev. Neurosci. 33 2011 199 209
7. M.A. DeCoster, K.L. Klette, E.S. Knight, and F.C. Tortella Sigma receptor-mediated neuroprotection against glutamate toxicity in primary rat neuronal cultures Brain Res. 671 1995 45 53
8. Y. Dun, M. Thangaraju, P. Prasad, V. Ganapathy, and S.B. Smith Prevention of excitotoxicity in primary retinal ganglion cells by (+)-pentazocine, a sigma receptor-1 specific ligand Investig. Ophthalmol. Vis. Sci. 48 2007 4785 4794
9. V. Francardo, F. Bez, T. Wieloch, H. Nissbrandt, K. Ruscher, and M.A. Cenci Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism Brain:J. Neurol. 2014
10. G. Garg, S. Vangveravong, C. Zeng, L. Collins, M. Hornick, Y. Hashim, D. Piwnica-Worms, M.A. Powell, D.G. Mutch, R.H. Mach, W.G. Hawkins, and D. Spitzer Conjugation to a SMAC mimetic potentiates sigma-2 ligand induced tumor cell death in ovarian cancer Mol. Cancer 13 2014 50
11. E. Griesmaier, A. Posod, M. Gross, V. Neubauer, K. Wegleiter, M. Hermann, M. Urbanek, M. Keller, and U. Kiechl-Kohlendorfer Neuroprotective effects of the sigma-1 receptor ligand PRE-084 against excitotoxic perinatal brain injury in newborn mice Exp. Neurol. 237 2012 388 395
12. Y. Ha, A.K. Shanmugam, S. Markand, E. Zorrilla, V. Ganapathy, and S.B. Smith Sigma receptor 1 modulates ER stress and Bcl2 in murine retina CellTissue Res. 356 2014 15 27
13. A.A. Hall, Y. Herrera, C.T. Ajmo Jr., J. Cuevas, and K.R. Pennypacker Sigma receptors suppress multiple aspects of microglial activation Glia 57 2009 744 754
14. T. Hayashi, and T.P. Su Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival Cell 131 2007 596 610
15. M.A. Hebert, and J.P. O'Callaghan Protein phosphorylation cascades associated with methamphetamine-induced glial activation Ann. NY Acad. Sci. 914 2000 238 262
16. A. Hyrskyluoto, I. Pulli, K. Tornqvist, T.H. Ho, L. Korhonen, and D. Lindholm Sigma-1 receptor agonist PRE084 is protective against mutant huntingtin-induced cell degeneration: involvement of calpastatin and the NF-kappaB pathway Cell DeathDis. 4 2013 e646
17. C. Katnik, W.R. Guerrero, K.R. Pennypacker, Y. Herrera, and J. Cuevas Sigma-1 receptor activation prevents intracellular calcium dysregulation in cortical neurons during in vitro ischemia J. Pharmacol. Exp. Ther. 319 2006 1355 1365
18. N. Kaushal, M. Elliott, M.J. Robson, A.K. Iyer, Y. Rojanasakul, A. Coop, and R.R. Matsumoto AC927, a sigma receptor ligand, blocks methamphetamine-induced release of dopamine and generation of reactive oxygen species in NG108-15 cells Mol. Pharmacol. 81 2012 299 308
19. N. Kaushal, M.J. Robson, A. Rosen, C.R. McCurdy, and R.R. Matsumoto Neuroprotective targets through which 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a sigma receptor ligand, mitigates the effects of methamphetamine in vitro Eur. J. Pharmacol. 724 2014 193 203
20. N. Kaushal, M.J. Seminerio, M.J. Robson, C.R. McCurdy, and R.R. Matsumoto Pharmacological evaluation of SN79, a sigma (sigma) receptor ligand, against methamphetamine-induced neurotoxicity in vivo Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol. 23 2013 960 971
21. D. Lobner, and P. Lipton Sigma-ligands and non-competitive NMDA antagonists inhibit glutamate release during cerebral ischemia Neurosci. Lett. 117 1990 169 174
22. R. Mancuso, S. Olivan, A. Rando, C. Casas, R. Osta, and X. Navarro Sigma-1R agonist improves motor function and motoneuron survival in ALS mice Neurother.: J. Am. Soc. Exp. Neurother. 9 2012 814 826
23. M. Martina, M.E. Turcotte, S. Halman, and R. Bergeron The sigma-1 receptor modulates NMDA receptor synaptic transmission and plasticity via SK channels in rat hippocampus J. Physiol. 578 2007 143 157
24. R.R. Matsumoto, W.D. Bowen, and T.P. Su Sigma Receptors: Chemistry, Cell Biology and Clinical Implications 2007 Springer New York, NY
25. J. Meunier, and T. Hayashi Sigma-1 receptors regulate Bcl-2 expression by reactive oxygen species-dependent transcriptional regulation of nuclear factor kappaB J. Pharmacol. Exp. Ther. 332 2010 388 397
26. J. Meunier, J. Ieni, and T. Maurice The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor Br. J. Pharmacol. 149 2006 998 1012
27. F.P. Monnet Sigma-1 receptor as regulator of neuronal intracellular Ca2+: clinical and therapeutic relevance Biol. Cell / Under Auspices Eur. Cell Biol. Organ. 97 2005 873 883
28. T. Mori, T. Hayashi, E. Hayashi, and T.P. Su Sigma-1 receptor chaperone at the ER-mitochondrion interface mediates the mitochondrion-ER-nucleus signaling for cellular survival PLoS One 8 2013 e76941
29. A. Pal, D. Fontanilla, A. Gopalakrishnan, Y.K. Chae, J.L. Markley, and A.E. Ruoho The sigma-1 receptor protects against cellular oxidative stress and activates antioxidant response elements Eur. J. Pharmacol. 682 2012 12 20
30. V.H. Perry, J.A. Nicoll, and C. Holmes Microglia in neurodegenerative disease Nat. Rev. Neurol. 6 2010 193 201
31. M. Peviani, E. Salvaneschi, L. Bontempi, A. Petese, A. Manzo, D. Rossi, M. Salmona, S. Collina, P. Bigini, and D. Curti Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation Neurobiol. Dis. 62 2014 218 232
32. G. Raivich, M. Bohatschek, C.U. Kloss, A. Werner, L.L. Jones, and G.W. Kreutzberg Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function Brain Res. Rev. 30 1999 77 105
33. M.J. Robson, R.C. Turner, Z.J. Naser, C.R. McCurdy, J.D. Huber, and R.R. Matsumoto SN79, a sigma receptor ligand, blocks methamphetamine-induced microglial activation and cytokine upregulation Exp. Neurol. 247 2013 134 142
34. M.J. Robson, R.C. Turner, Z.J. Naser, C.R. McCurdy, J.P. O'Callaghan, J.D. Huber, and R.R. Matsumoto SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation Exp. Neurol. 254 2014 180 189
35. A.L. Sheldon, and M.B. Robinson The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention Neurochem. Int. 51 2007 333 355
36. Y.C. Shen, Y.H. Wang, Y.C. Chou, K.T. Liou, J.C. Yen, W.Y. Wang, and J.F. Liao Dimemorfan protects rats against ischemic stroke through activation of sigma-1 receptor-mediated mechanisms by decreasing glutamate accumulation J. Neurochem, 104 2008 558 572
37. S.B. Smith, J. Duplantier, Y. Dun, B. Mysona, P. Roon, P.M. Martin, and V. Ganapathy In vivo protection against retinal neurodegeneration by sigma receptor 1 ligand (+)-pentazocine Investig. Ophthalmol. Vis. Sci. 49 2008 4154 4161
38. T.P. Su, T. Hayashi, T. Maurice, S. Buch, and A.E. Ruoho The sigma-1 receptor chaperone as an inter-organelle signaling modulator Trends Pharmacol. Sci. 31 2010 557 566
39. I. Tabas, and D. Ron Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress Nat. Cell Biol. 13 2011 184 190
40. K.T. Tchedre, and T. Yorio Sigma-1 receptors protect RGC-5 cells from apoptosis by regulating intracellular calcium, Bax levels, and caspase-3 activation Investig. Ophthalmol. Vis. Sci. 49 2008 2577 2588
41. K. Vagnerova, P.D. Hurn, A. Bhardwaj, and J.R. Kirsch Sigma 1 receptor agonists act as neuroprotective drugs through inhibition of inducible nitric oxide synthase Anesth. Analg. 103 2006 430 434
42. A. van Waarde, A.A. Rybczynska, N. Ramakrishnan, K. Ishiwata, P.H. Elsinga, and R.A. Dierckx Sigma receptors in oncology: therapeutic and diagnostic applications of sigma ligands Curr. Pharm. Des. 16 2010 3519 3537
43. N.J. Van Wagoner, and E.N. Benveniste Interleukin-6 expression and regulation in astrocytes J. Neuroimmunol. 100 1999 124 139
44. L. Wang, J.A. Eldred, P. Sidaway, J. Sanderson, A.J. Smith, R.P. Bowater, J.R. Reddan, and I.M. Wormstone Sigma 1 receptor stimulation protects against oxidative damage through suppression of the ER stress responses in the human lens Mech. Ageing Dev. 133 2012 665 674
45. X. Wang, and W.D. Bowen Sigma-2 receptors mediate apoptosis in SK-N-SH neuroblastoma cells via caspase-10-dependent Bid cleavage and mitochondrial release of endonuclease G and apoptosis-inducing factor Soc. Neurosci. 2006
46. J. Xu, C. Zeng, W. Chu, F. Pan, J.M. Rothfuss, F. Zhang, Z. Tu, D. Zhou, D. Zeng, S. Vangveravong, F. Johnston, D. Spitzer, K.C. Chang, R.S. Hotchkiss, W.G. Hawkins, K.T. Wheeler, and R.H. Mach Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site Nat. Commun. 2 2011 380
47. S. Yang, A. Bhardwaj, J. Cheng, N.J. Alkayed, P.D. Hurn, and J.R. Kirsch Sigma receptor agonists provide neuroprotection in vitro by preserving bcl-2 Anesth. Analg. 104 2007 1179 1184
48. Z.J. Yang, E.L. Carter, M.T. Torbey, L.J. Martin, and R.C. Koehler Sigma receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine modulates neuronal nitric oxide synthase/postsynaptic density-95 coupling mechanisms and protects against neonatal ischemic degeneration of striatal neurons Exp. Neurol. 221 2010 166 174
49. X.J. Zhang, L.L. Liu, S.X. Jiang, Y.M. Zhong, and X.L. Yang Activation of the zeta receptor 1 suppresses NMDA responses in rat retinal ganglion cells Neuroscience 177 2011 12 22
50. Y. Zhang, Y. Shi, L. Qiao, Y. Sun, W. Ding, H. Zhang, N. Li, and D. Chen Sigma-1 receptor agonists provide neuroprotection against gp120 via a change in bcl-2 expression in mouse neuronal cultures Brain Res. 1431 2012 13 22